跳至主要内容
临床试验/NCT07722013
NCT07722013招募中不适用

Intermittent Ephedrine Boluses for Prophylaxis Against Postinduction Hypotension in High-risk Patients Undergoing Major Abdominal Surgery: a Randomized Double-blinded Controlled Trial: a Randomized Double-blinded Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2026年8月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
124
试验地点
1
主要终点
incidence of postinduction hypotension

研究概览

简要总结

The aim of this work is to assess the efficacy of intermittent ephedrine boluses in prophylaxis against postinduction hypotension in high-risk patients undergoing major abdominal surgery, compared to standard care.

详细描述

Fluid responders (≥20% rise in perfusion index on passive leg raising) will receive 500-mL Ringer's boluses (up to 1500 mL). Anesthesia will be induced with fentanyl/propofol, intubated after neuromuscular blockade, and maintained with isoflurane (1.2% end-tidal). Study drug will be given at induction and every 5 minutes for 20 minutes, withheld if MAP ≥80 mmHg or a recent vasopressor dose. Hypotension (MAP <65 mmHg) will be treated with 0.1 mg/kg ephedrine boluses (max 9 mg single). Post-incision care follows anesthetist discretion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients aged >50 years,
  • •weight >50 kg,
  • •American Society of Anesthesiologists (ASA) Physical Status score of > I,
  • •undergoing major abdominal surgery

排除标准

  • •Severe cardiac morbidities (impaired contractility with ejection fraction < 40%, heart block, significant uncontrolled arrhythmias, tight stenotic valvular lesions)
  • •Acute cardiovascular pathologies: acute/decompensated heart failure, acute coronary syndrome
  • •Uncontrolled hypertension (systolic blood pressure>150 mmHg)
  • •Preoperative HR more than 110 bpm despite proper fluid management and patients with renal impairment
  • •Renal impairment
  • •Patients on vasopressor infusion,
  • •Allergy of any of the study drugs

研究组 & 干预措施

ephedrine

Active Comparator

ephedrine boluses

干预措施: Ephedrine (Drug)

control

Placebo Comparator

Normal Saline boluses

干预措施: Normal Saline (Drug)

结局指标

主要结局

incidence of postinduction hypotension

时间窗: from induction of anesthesia until 20 minutes after induction

mean arterial pressure \< 65 mmHg

次要结局

  • area under mean arterial pressure of 65 mmHg(from induction of anesthesia until 20 minutes after induction)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Hasanin

Professor

Cairo University

研究点 (1)

Loading locations...

相似试验